- Home
- SCLX vs CBFV Comparison
SCLX vs CBFV Comparison
Compare SCLX & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- CBFV
- Stock Information
- Founded
- SCLX 2011
- CBFV 1901
- Country
- SCLX United States
- CBFV United States
- Employees
- SCLX N/A
- CBFV 162
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- CBFV Major Banks
- Sector
- SCLX Health Care
- CBFV Finance
- Exchange
- SCLX Nasdaq
- CBFV Nasdaq
- Market Cap
- SCLX 130.1M
- CBFV 148.0M
- IPO Year
- SCLX N/A
- CBFV N/A
- Fundamental
- Price
- SCLX $0.61
- CBFV $28.69
- Analyst Decision
- SCLX Strong Buy
- CBFV Hold
- Analyst Count
- SCLX 3
- CBFV 3
- Target Price
- SCLX $11.33
- CBFV $25.67
- AVG Volume (30 Days)
- SCLX 184.3K
- CBFV 6.4K
- Earning Date
- SCLX 11-26-2024
- CBFV 10-25-2024
- Dividend Yield
- SCLX N/A
- CBFV 3.46%
- EPS Growth
- SCLX N/A
- CBFV 62.63
- EPS
- SCLX N/A
- CBFV 4.36
- Revenue
- SCLX $50,833,000.00
- CBFV $67,214,000.00
- Revenue This Year
- SCLX $32.77
- CBFV N/A
- Revenue Next Year
- SCLX $50.71
- CBFV $0.61
- P/E Ratio
- SCLX N/A
- CBFV $6.62
- Revenue Growth
- SCLX 9.41
- CBFV 24.04
- 52 Week Low
- SCLX $0.54
- CBFV $20.75
- 52 Week High
- SCLX $2.63
- CBFV $29.90
- Technical
- Relative Strength Index (RSI)
- SCLX 28.71
- CBFV 51.98
- Support Level
- SCLX $0.73
- CBFV $28.52
- Resistance Level
- SCLX $1.14
- CBFV $29.20
- Average True Range (ATR)
- SCLX 0.11
- CBFV 0.57
- MACD
- SCLX -0.04
- CBFV -0.05
- Stochastic Oscillator
- SCLX 11.99
- CBFV 56.20
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.